Posts Tagged: "Ronald Kern"

The increasingly crowded and complex biologics space is evolving faster than the ability of companies to manage sequence information to secure and protect their valuable IP assets. Missing critical sequence IP information during biologics R&D can delay progress and result in weaker patent claims, missed opportunity, and greater legal risks. Join us on Thursday, June 22, 2023, at 12:00 PM…